Ginsenoside K
Specifications
39262-14-1CAS Number
683-216-3EC Number
(2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triolIUPAC Name
C36H62O8Chemical Formula
622.9 g/molMolecular Weight
Ginsenoside K; RefChem:639972; ginsenoside C-K; 39262-14-1; ginsenoside CK; ginsenoside compound K; ginsenoside M1; 20(S)-GINSENOSIDE CK; 20(S)-Ginsenoside C-K; MFCD07772261; (2s,3r,4s,5s,6r)-2-[(2s)-2-[(3s,5r,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol; 3-O-Deglucosylginsenoside F2; Protopanaxadiol 20-O-glucoside; CHEMBL3355096; CHEBI:77146; G8D4792Q7K; (20S)-20-(beta-D-Glucopyranosyloxy)dammara-24-ene-3beta,12beta-diol; (2S,3R,4S,5S,6R)-2-{[(2S)-2-[(1S,3aR,3bR,5aR,7S,9aR,9bR,11R,11aR)-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-en-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol; GM1 saponin; (2S,3R,4S,5S,6R)-2-(((S)-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-methylhept-5-en-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; IH901 cpd; ginsenosideCK; CompoundK; Compound-K; ginsenoside-C-K; Compound CK; Ginsenoside compound K; Ginsenoside K; IH901; Ginsenoside metabolite M1; Ginsenoside K (Standard); (20S)-ginsenoside C-K; NT3 VAN SC6; Ginsenoside C-K (Standard); UNII-G8D4792Q7K; 20-O-(beta-D-glucopyranosyl)-20(S)-protopanaxadiol; orb1222288; orb1303718; orb3139325; SCHEMBL18179307; DTXSID60431770; GLXC-03739; HY-N0904; BDBM50023446; IH 901; (3beta,12beta)-3,12-dihydroxydammar-24-en-20-yl beta-D-glucopyranoside; AKOS037514664; CCG-270260; CS-3840; EBC-615548; LMPR0106080023; MG33283; AC-33947; AS-82692; DA-63760; G0590; C22127; 20-O-beta-Glucopyranosyl-20(S)-protopanaxadiol; ginsenoside C-K; Protopanaxadiol 20-O-glucoside; G337543; BRD-K01942833-001-01-8; Q27146701; 20-(beta-D-glucopyranosyloxy)dammar-24-ene-3beta,12-diol; 20(S)-PROTOPANAXADIOL 20-O-.BETA.-D-GLUCOPYRANOSIDE; 20beta-(beta-D-glucopyranosyloxy)dammar-24-ene-3beta,12beta-diol; 3beta,12beta-dihydroxydammar-24-en-20S-yl-beta-D-glucopyranoside; (20R)-3beta,12beta-Dihydroxydammar-24-en-20-yl beta-D-glucopyranoside; (3.BETA.,12.BETA.)-3,12-DIHYDROXYDAMMAR-24-EN-20-YL .BETA.-D-GLUCOPYRANOSIDE; .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,12.BETA.)-3,12-DIHYDROXYDAMMAR-24-EN-20-YL; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1,5-dimethyl-hex-4-enoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triolSynonyms